BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
Denver would eliminate its limit on the number of needle exchange programs that can operate in the city and remove ...
FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback